Revascular Therapeutics, Inc.
Country not established
- Devices
- 1
What Revascular Therapeutics, Inc. makes
Revascular Therapeutics, Inc. manufactures the RVT CTO Device, a medical device designed for treating chronic total occlusions (CTOs) in coronary arteries. This device is intended to facilitate revascularization by improving blood flow in blocked vessels, supporting interventional cardiology procedures.
The RVT CTO Device is classified as a Class II medical device under FDA regulations and is authorised via the 510(k) pathway. The company is based in the United States.
Catalogue
Rvt Cto Device Ref K101599
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Revascular Therapeutics, Inc. have in the registry?
The registry currently lists 1 device for Revascular Therapeutics, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Revascular Therapeutics, Inc.'s devices?
Among its 1 most recently registered device, Revascular Therapeutics, Inc. has devices listed in FDA 510(k) (1 device).
What risk classes do Revascular Therapeutics, Inc.'s devices fall under?
Among its 1 most recently registered device, the classes recorded for Revascular Therapeutics, Inc.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Revascular Therapeutics, Inc. in the registry?
The most recently registered devices listed for Revascular Therapeutics, Inc. include RVT CTO DEVICE.